Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Salvator Tiano
Period: Reporting period mapped to calendar 2026 Q3.
- Questions
- 4on tracked calls
- Challenge rate
- 0%none of 4 questionsLimited sample
- Companies
- 4questioned at least once
- Reporting periods
- 1with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right. See how we grade analysts on earnings-call questions.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 4 of 4 questions from 4 companies
LINLinde plc1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q3
what do you think would have been your price power to recover these costs should conditions for these end markets
Show response
Said cost recovery is contractual and was net dilutive to Americas margins, but did not quantify a one-off margin benefit.
LYBLyondellBasell1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q3
Does this mean that MoReTec-2 is pushed further to the right or potentially canceled?
Show response
Vanacker said MoReTec-2 would likely go to Europe given weak U.S. regulatory support and called the sale a capital allocation move, but did not address a Valero feedstock deal.
PPGPPG Industries1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q3
is this purely pricing, or are there any other things that were taken in the mix when we think about the neutrality?
Show response
Knavish said commercial actions are well over 90% price and cautioned against assuming a near-term price-cost tailwind.
SHWThe Sherwin-Williams Company1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q3
Can you provide a little bit about the cadence of sales over Q3 and what you are seeing in October
Show response
Petz walked through share gains by housing segment but did not describe the monthly cadence or October trends that were asked about.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| LIN Linde plc | 1 | —Rate withheld: fewer than 3 questions |
| LYB LyondellBasell | 1 | —Rate withheld: fewer than 3 questions |
| PPG PPG Industries | 1 | —Rate withheld: fewer than 3 questions |
| SHW The Sherwin-Williams Company | 1 | —Rate withheld: fewer than 3 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2026 Q3 | 4 | 0%none of 4 questions | 4 |
- 2026 Q34 questions · challenge rate 0% (none of 4 questions) · 4 companies
Topics
Topics tagged on this analyst’s questions.
- Pricing2
- Cost Pressure2
- Capex Investment1
- Regulation Policy1
- M&A1
- Demand1
- Macroeconomic1